Sr. Princ. Scientist
Merck & Co., Inc., Kenilworth, NJ, USA
Disclosure: Merck Sharp & Dohme Corp, a subsidiary of Merck & Co., Inc., Kenilworth, NJ, USA (Employee, Shareholder)
Jakub Simon MD, MS, Senior Principal Scientist, Clinical Research, GCD Vaccines- Pediatrics, Merck & Co., Inc., Kenilworth, NJ, USA where he works on the Ebola, pneumococcal, hepatitis A, hepatitis B, Haemophilus influenzae type B, and COVID-19 vaccine programs. Dr. Simon is trained as a pediatric infectious disease physician with over 15 years of clinical vaccine development experience in academia, biotechnology, and large pharma. Prior to Merck, Dr. Simon served as Senior Director of Clinical Development at PaxVax, where he worked on the licensure of the oral cholera vaccine, Director of Clinical Vaccine Development at NanoBio where he worked on intranasal influenza, respiratory syncytial virus, and anthrax vaccines, as well as Assistant Professor of Pediatric Infectious Diseases at the University of Maryland where he worked on oral Shigella, oral cholera, intramuscular herpes simplex, intranasal measles, and other vaccines with specific focus on the identification of immune correlates of protection.
